Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice

Brain Research

Volumn 763, Issue 2, 1997, Pages 215-220

  Kaplan, Gary B ^a   Leite Morris, Kimberly A ^a  

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adenosine; Drug tolerance; Drug withdrawal; Morphine; Mouse brain; Nucleoside transporter; Opiate; Opioid

Indexed keywords

MORPHINE; OPIATE AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; DRUG DEPENDENCE; DRUG TOLERANCE; DRUG WITHDRAWAL; HYPOTHALAMUS; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

ADENOSINE; ANIMALS; BINDING SITES; BRAIN STEM; CARRIER PROTEINS; CEREBELLUM; CORPUS STRIATUM; DRUG TOLERANCE; HYPOTHALAMUS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED STRAINS; MORPHINE; NARCOTICS; NUCLEOSIDE TRANSPORT PROTEINS; UP-REGULATION;

EID: 0030813894     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00413-7     Document Type: Article

References (32)

1. Ahlijanian M.K., Takemori A.E. Changes in adenosine receptor sensitivity in morphine-tolerant and -dependent mice. J. Pharmacol. Exp. Ther. 236:1986;615-620.
2. Aley K.O., Green P.G., Levine J.D. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J. Neurosci. 15:1995;8031-8038.
3. Barjavel M.J., Scherrman J.M., Bhargava H.N. Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: a microdialysis study. Br. J. Pharmacol. 116:1995;3205-3210.
4. Bonci A., Williams J.T. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron. 16:1996;631-639.
5. D.B. Bylund and H.I. Yamamura, Methods for receptor binding. In: H.I. Yamamura, S.J. Enna and M.J. Kuher (Eds.), Methods in Neurotransmitter Receptor Analysis, Raven, New York, NY, 1990, pp. 1-35.
6. Cunha R.A., Vizi E.S., Ribeiro J.A., Sebastiao A.M. Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J. Neurochem. 67:1996;2180-2187.
7. De Montis M.G., Devoto P., Meloni D., Saba P.L., Tagliamonte A. Decreased adenosine A2 receptor function in morphine dependent rats. Pharmacol. Res. 25(Suppl.):1992;232-233.
8. Desole M.S., Esposito G., Fresu L., Migheli R., Enrico P., Mura M.A., DeNatale G., Miele E., Miele M. Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat. Brain Res. 723:1996;154-161.
9. Diana M., Pistis M., Muntoni A., Gessa G. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J. Pharmacol. Exp. Ther. 272:1995;781-785.
10. DiChiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38:1995;95-137.
11. Duman R.S., Tallman J.F., Nestler E.J. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J. Pharmacol. Exp. Ther. 246:1988;1033-1039.
12. Ferre S., Von Euler G., Johansson B., Fredholm B., Fuxe K. Stimulation of high affinity adenosine A-2 receptors decreases the affinity of dopamine D-2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. USA. 88:1991;7237-7241.
13. Ferre S., Popoli P., Gimenez-Llort L., Finnman U.-B., Martinez E., Scotti De Carolis A., Fuxe K. Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors. NeuroReport. 6:1994;73-76.
14. Ferre S., Popoli P., Tinner-Staines B., Fuxe K. Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites. Neuroscience. 208:1996;109-112.
15. Fredholm B.B., Vernet L. Morphine increases depolarization induced purine release from rat cortical slices. Acta Physiol. Scand. 104:1978;502-504.
16. F.D. Geiger and D.M. Fyda, Adenosine transport in nervous system tissues. In: T.W. Stone (Ed.), Adenosine in the Nervous System, Academic Press, San Diego, CA, 1991, pp. 1-24.
17. 3H]adenosine from rat brain synaptosomal preparations. J. Neurochem. 64:1995;2105-2110.
18. Jin S., Johansson B., Fredholm B.B. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J. Pharmacol. Exp. Ther. 267:1993;801-808.
19. Kaplan G.B., Leite-Morris K.A., Sears M.T. Alterations in adenosine A1 receptors in morphine dependence. Brain Res. 657:1994;347-350.
20. Kaplan G.B., Sears M.T. Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs. Psychopharmacology. 123:1996;64-70.
21. Kaplan G.B. Cross-regulation of neurotransmitter signaling systems in opiate dependence. J. Biol. Psychiatry. 41:1997;585.
22. Keil G.J., DeLander G.E. Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors. J. Pharmacol. Exp. Ther. 274:1995;1387-1392.
23. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677.
24. 3H]Nitrobenzylthioinosine binding as a probe for the study of adenosine uptake sites in brain. J. Neurochem. 39:1982;184-191.
25. Miras-Portugal M.T., Sen R.P., Delicado E.G. Nucleoside transport in neurons. Regulation by secretagogues and effectors of protein kinases A and C. Nucleosides Nucleotides. 10:1991;965-973.
26. 2a receptors. Brain Res. 716:1996;107-117.
27. Phillis J.W., Jiang Z.G., Chelack B.J., Wu P.H. Morphine enhances adenosine release from the in vivo rat cerebral cortex. Eur. J. Pharmacol. 65:1979;97-100.
28. Poon A., Sawynok J. Antinociception by adenosine analogs and adenosine kinase inhibitor: dependence on formalin concentration. Eur. J. Pharmacol. 286:1995;177-184.
29. Sen R.P., Delicado E.G., Miras-Portugal M.T. Effect of forskolin and cyclic AMP analog on adenosine transport in cultured chromaffin cells. Neurochem. Int. 17:1990;523-528.
30. Sweeney M.I. Adenosine release and uptake in cerebellar granule neurons both occur via an equilibrative nucleoside carrier that is modulated by G proteins. J. Neurochem. 67:1996;81-88.
31. Sweeney M.I., White T.D., Sawynok J. Morphine-evoked release of adenosine from the spinal cord occurs via a nucleoside carrier with differential sensitivity to dipyridamole and nitrobenzylthioinosine. Brain Res. 614:1993;301-307.
32. Thorn J.A., Jarvis S.A. Adenosine Transport. Gen. Pharmacol. 27:1996;613-620.